THYMOGLOBULIN: payments to doctors
Payments that named THYMOGLOBULIN as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.5M
- Providers
- 999
- Transactions
- 3,017
- Average per transaction
- $1,155
The per-transaction average — $1,155 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 999 providers the average total is $3,489, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi-aventis U.S. LLC | $2,596,054 | 74.5% |
| Sanofi | $889,801 | 25.5% |
| Sanofi US Services Inc. | $29 | 0.0% |